Background/Aims: Inhibition of Drp-1-mediated mitochondrial fission limits reactive oxygen species (ROS) production and apoptosis in cardiomyocytes subjected to ischemia/reperfusion injury. It remains unknown if Dynamin 2 inhibition results in similar protective effects. Here we studied the role of Dynamin 2 in cardiomyocyte oxidative stress-induced apoptosis and ROS production. Methods: The effect of lentiviral shRNA (lv5-shRNA) mediated Dynamin 2 knockdown on apopotosis, mitochondria, and ROS production were studied in neonatal mouse cardiomycytes, which were further treated with either selective Drp1 inhibitor mdivi-1 or the Dynamin 2/Drp1 inhibitor Dynasore. Apoptosis was evaluated by flow cytometry. Mitochondrial morphology and transmembrane potential (ΔΨm) were studied by confocal microscopy, and ROS production was detected by dichlorofluorescein diacetate. Results: Inhibition of Drp1 and Dynamin 2 protected against mitochondrial fragmentation, maintained ΔΨm, attenuated cellular ROS production and limited apoptosis. Moreover, Lv5-shRNA mediated knockdown of Dynamin 2 alleviated mitochondrial fragmentation, and reduced both ROS production and oxidative stress-induced apoptosis. The protective effects of Dynamin 2 knockdown were enhanced by Dynasore, indicating an added benefit. Conclusions: Oxidative stress-induced apoptosis and ROS production are attenuated by not only Drp1 inhibition but also Dynamin 2 inhibition, implicating Dynamin 2 as a mediator of oxidative stress in cardiomyocytes.
Introduction
Recently, it has been found that the fine balance between mitochondrial fusion and fission controlled by local GTP gradients and that mitochondrial energetics may determine the cell fate [1, 2] . This balance can be disrupted by a variety of factors, including oxidative anti-Dynamin 2 antibody (both at 1:500), or anti-β-actin (1:2000) in TBST overnight at 4°C. Membranes were washed thrice with TBST and incubated with secondary antibody (horseradish peroxidase-conjugated, 1:2500) at room temperature for 1 h. After washing 4-5 times with TBST, proteins were visualized with an enhanced chemiluminescence (ECL) detection reagent (Beit Haemek, Kibbutz Beit Haemek, Israel).
Preparation of primary neonatal mouse cardiomyocyte Lv5-shRNA
Packaging, purification, and titer determination of the lentivirus were performed as previously described [12] . The recombinant viruses were produced by calcium phosphate transfection of HEK293T cells using standard protocols [13] . Briefly, 293T cells were cultured in Dulbecco's modified Eagles's medium. The cells were co-transfected with the lentiviral vector (10µg), and the lentiviral packaging vectors pRSV-REV (2µg), pMDLg/RRE (5µg), and the vesicular stomatitis virus G glycoprotein (VSVG) expression vector pMD2G (3µg). The viruses were collected from the culture supernatant 48 h post-transfection, concentrated by ultra-centrifugation for 2 h at 25,000 rpm, and re-suspended in phosphate-buffered saline (PBS). Titers were determined by infecting 293T cells with serial dilutions of concentrated lentivirus and then counting eGFP positive cells after 48h under fluorescent microscopy. Lentiviral transduction in mouse neonatal cardiomyocytes: At day 2-3 post-culture, the cells were incubated with lentivirus at various ''multiplicity of infection" (MOI) for 3, 4, and 5 days, respectively. Polybrene (10µg/ml) was added to increase the efficiency of lentiviral transduction [14] . Neonatal mouse cardiomyocytes were infected with lentivirus transducing negative control shRNA (Lv5-shRNA NC ) or Dynamin 2 lentivirus shRNA (Lv5-shRNA D2 -1 or Lv5-shRNA D2 -2) for 72 h and processed for immunoblot analysis. Immunoblot analysis was visualized with anti-Dynamin 2 or anti-β-actin antibodies. For all other experiments, only the control lv5-shRNA NC and the more effective lv5-shRNA D2 -2 were used.
Measurement of apoptosis in neonatal mouse cardiomyocytes
Cell apoptosis was measured by flow cytometry using propidium iodide (PI) and Annexin-V staining. Annexin-V-only positive cells indicated early apoptosis, whereas PI-positive cells indicated damaged cell membranes and secondary/late apoptosis. For the assay, cells were dissociated using trypsin and then re-suspended in buffer to a final concentration of 1×106 cells/L. Each cell sample was incubated with annexin-V (5µL) and PI (4 µl) in the dark at room temperature for 20 minutes and then analyzed using a FC500 MPL flow cytometer (Beckman Coulter, FL). The results were analyzed using FlowJo Software (TreeStar, Shenzhen, China) [15] .
Analysis of live-cell mitochondrial morphology
Mitochondrial microscopy was performed by visualizing mitochondria using confocal fluorescence microscopy (Leica TCS SP5II, Germany) as previously described [16] . We selected 500nM as a working concentration for MitoTracker® Red probe. After cardiomyocytes were stained with MitoTracker® Red CMXRos (500nM) for 30min, cells were pretreated with either control, Dynasore or mdivi-1 in indicated doses for specific time duration before being exposed to normal condition or 30µM H 2 O 2 for 30min. Before and after exposure to H 2 O 2 , cells were visualized using confocal fluorescence microscopy (Ex (nm) *: 579, Em (nm) *: 599) and a high resolution Cool SNAP HQ2 camera.
Measurement of mitochondrial transmembrane potential ΔΨm
Quantification of mitochondrial membrane depolarization was carried out by measuring the fluorescence intensity of the membrane-permeant cationic probe tetramethylrhodamine methyl ester (TMRM). TMRM is a cationic fluorescent dye that accumulates inside the mitochondrial matrix by the membrane potential. The resulting signal of TMRM-stained cells thus represents only the probe accumulated in the intact mitochondria. A collapse on mitochondrial membrane is indicated by a decrease in fluorescence output. Induction of the mPTP opening is seen by collapse of the mitochondrial membrane potential (ΔΨm) [17, 18] . ΔΨm was measured with the non-quenching fluorescence methods (Molecular Probes, Sigma). Neonatal mouse cardiomyocytes were stained with TMRM (600 nM) for 20 min at 37°C in the dark. Then cells were stained with TMRM (150 nM) for 10 min at 37°C in the dark. The cells were then washed twice with PBS for 10min each time. Cells were pretreated with the same protocols as previously mentioned. Cells were visualized using confocal fluorescence microscopy (Leica TCS SP5II, Germany), and a high resolution Cool SNAP HQ2 camera. For TMRM fluorescence, the cells were illuminated by using the 543-nm emission line of a He-Ne laser, and the fluorescence of TMRM was collected using a 570-nm long-pass filter. mPTP opening was confirmed in this model by using the known mPTP inhibitors mdivi-1.
Measurement of mitochondrial ROS production in neonatal mouse cardiomyocytes
Total ROS production in neonatal mouse cardiomyocytes exposed to oxidative stress was determined using dichlorofluorescein diacetate (DCFDA) fluorescence methods [15] . Briefly, cells were loaded with 10 µM (DCFDA) for 45 min. ROS levels were measured using Fluoromax-3 spectrofluorimeter with excitation wavelength set at 485 nm and emission at 530 nm, and it was quantified as a change in the fluorescence because of the conversion of non-fluorescent dichlorofluorescein diacetate to the highly fluorescent compound 2',7'-dichlorofluorescein (DCF) in the cells. Aliquots of cell suspension (100 µl) were incubated for 10 min with curcumin and re-suspended in HBS prior to each experiment, which potentially eliminated the interference of curcumin in fluorescence assays.
Data analysis
Statistical analysis was performed using SPSS16.0. The data were presented as means ± standard deviation. Difference between control and experimental groups were determined using a one-way analysis of variance (ANOVA) for multiple groups. Difference between every two groups was assessed using Bonferroni post hoc test. For comparison between two groups with timed repeated measurements, a twoway ANOVA (treatment and time were considered as the two variances) was used. P<0.05 was considered to be statistically significant.
Results

Dynamin 2 knockdown reduces hydrogen peroxide-induced apoptosis in neonatal mouse cardiomyocytes
Our previous study found that Dynasore protects adult mouse cardiomyocytes against oxidative stress, and dramatically reduced infarct size (from 39.6% to 8.1%, near 80% reduction) in Langendorff perfused adult mouse hearts following 30 minutes global ischemia and 60 minutes of reperfusion [9] . In the same adult mouse I/R model, we further identified that, as compared to DMSO control, 1 µM Dynasore pretreatment prevented the elevation of LVEDP [9] , achieved significant recoveries of -dp/dt and +dp/dt, and decreased the Tau (p<0.05) (Data not shown). In addition to Drp1, Dynasore also inhibits the GTPase activity of Dynamin 2, mutation of which is associated with abnormal mitochondrial function [10] . Thus Dynamin 2 inhibition may alter mitochondrial related apoptosis, contributing to the significant cardioprotective effect by low dose Dynasore. Given it is not possible to study apoptosis in isolated adult cardiomyocytes which only survive 3 days in culture, we used neonatal mouse cardiomyocytes to study the effect of Dynamin 2 knockdown on cell apoptosis following oxidative stress. Neonatal mouse cardiomyocytes were treated with Lv5-shRNA D2 -1 or Lv5-shRNA D2 -2 to specifically knock down Dynamin 2 and compared to a non-targeting negative control Lv5-shRNA NC (shRNA-NC). As indicated in Fig. 1A , Lv5-shRNA D2 -2 was the effective shRNA in knocking down Dynamin 2, which induced a near 70% decrease in the protein expression of Dynamin 2 (to 34.7%) by Western blotting. Thus, Lv5-shRNA D2 -2 was used in the following experiments in the current study. After knockdown, neonatal cardiomyocytes were subjected to H 2 O 2 treatment and apoptosis was then analyzed by flow cytometry (Fig. 1B, quantification in Fig. 1C ). Our results indicated that apoptosis was significantly decreased in Lv5-shRNA D2 -2 treated cardiomyocytes (28.09% vs 44.1%,P<0.01) similar to the effect of Drp1 inhibition by mdivi-1. Between the Lv-shRNA D2 -2 and Lv-shRNA NC treated groups, the apoptosis rate was 6.78% vs 9.97% (p<0.001) with 10µM Dynasore pretreatment, and 14.67% vs 14.9% (p>0.05) with 50µM mdivi-1 pretreatment, respectively. The further decrease in oxidative stress-induced apoptosis after higher doses of Dynasore pretreatment indicates an additive effect of Dynamin 2 inhibition to Drp1 inhibition. These results indicate that Dynamin 2 is involved in cardiomyocyte apoptosis and cell survival. Apoptosis assay standardization was done (Data not shown). -shR-NA NC or  dynamin  2 targ e t i n g Lv5-shR-N A D 2 -1 a n d Lv5-shR-NA D2 -2. Lv5-shRNA D2 -2 induces a near 70% reduction in dynamin 2 protein as indicated in the quantification data included in the bar graph（b）. B: Both shRNA-mediated dynamin2 knockdown and Dynasore diminish the apoptotic hallmarks in the neonatal mouse cardiomyocytes. (a) The cardiomyocytes-shRNA NC were pre-treated with Mdivi-1 (50μM) / Dynasore (1μM) / dynasore (3μM) / dynasore (10μM) respectively before being exposed to H 2 O 2 (30μM) for 30min. (b) The cardiomyocytes-shRNA D2 -2 were pre-treated with Mdivi-1 (50μM) / Dynasore (1μM) / dynasore (3μM) / dynasore (10μM) respectively before being exposed to Figure 2C indicate a significant loss of TMRM fluorescence, accompanied by a decrease in ΔΨm after the cell exposure to 30µM H 2 O 2 for 30min. Similarly, 50µM mdivi-1 protected TMRM fluorescence and ΔΨm. Dynasore protected the mitochondrial transmembrane potential ΔΨm in neonatal mouse cardiomyocytes as well (Fig. 2C, D) . Furthermore, the beneficial effect of Dynasore on mitochondrial morphology and ΔΨm was also dose-dependent (P<0.001, Fig. 2D ). Interestingly, as compared to mdivi-1, Dynasore tended to have a greater effect on mitochondrial transmembrane potential. Since low dose Dynasore (1µM) is already sufficient to preserve cardiomyocyte survival [9] , it is likely that, in addition to the inhibition of Drp1-mediated mitochondrial fission, the cardioprotective effect of Dynasore is mediated by its inhibition of another player, possibly Dynamin 2. The involvement of Dynamin 2 was further supported by a significant increase in Dynamin 2 protein levels following oxidative stress, which can be reduced by Dynasore (P<0.001, Fig. 3 ). Similarly, Drp1 was also increased after oxidative stress (P<0.01, Fig. 3 ), which was reduced by both mdivi-1 and 10 µM Dynasore (P<0.01, P<0.001, Fig. 3 ). 
Dynamin 2 knockdown protects mitochondrial morphology and ΔΨm in stressed neonatal mouse cardiomyocytes
Because Dynamin 2 knockdown protects cell apoptosis which is linked to mitochondrial function (Fig. 1) , it is logical to hypothesize that Dynamin 2 inhibition protects mitochondrial function. To test whether Dynamin 2 knockdown affects mitochondrial network, we then analyzed mitochondrial morphology in Lv5-shRNA D2 -2 treated neonatal mouse cardiomyocytes subjected to H 2 O 2 . Cardiomyocytes were then labeled with MitoTracker for analysis of mitochondrial morphology, or TMRM for measurement of mitochondrial potential ΔΨm. As indicated in Fig. 4 , when compared to negative control Lv5-shRNA NC (Fig.  4A) , Lv5-shRNA D2 -2 (Fig. 4B) protected elongated mitochondrial network with and without exposure to oxidative stress (p<0.01, Fig. 4C ). Consistently, in control Lv5-shRNA NC treated cardiomyocytes, Dynasore elongated mitochondria in a dose-dependent fashion, with 10µM of Dynasore achieving the similar protective effect of mdivi-1 (Fig. 4A) . As predicted, in cells with Dynamin 2 knockdown by Lv5-shRNA D2 -2, there was significant improvement of mitochondrial morphology in 1µM and 3µM Dynasore similar to the maximal beneficial effect provided by 10µM Dynasore and mdivi-1 in cardiomyocytes without Dynamin 2 (Fig. 4C) . Similar effects on protecting mitochondrial transmembrane potential ΔΨm were observed (Fig. 5) . These results suggested that Dynamin 2 is involved in dynamic equilibrium between mitochondrial fusion and fission, contributing to the cardiomyocyte protective effect by low dose Dynasore.
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Dynamin 2 knockdown reduces the production of mitochondrial ROS in neonatal mouse
cardiomyocytes ROS are generated in mitochondria as a result of the uncoupling of the electron transport chain which is a step in the intrinsic apoptotic pathway [19, 20] . As a consequence, ROS is a common inducer of mPTP opening, promoting oxidative damage of cell macromolecules and leading to apoptosis in I/R injured myocardium [21, 22] . We evaluated the effect of Dynasore on H 2 O 2 -induced intracellular ROS production (data not shown). Our results indicated that pre-treating cells with 1µM, 3µM, 10µM Dynasore and 50µM mdivi-1 significantly reduced H 2 O 2 -induced ROS generation, although no significant difference was observed among pretreatment groups with different doses of Dynasore and mdivi-1(P>0.05). The data indicate that ROS reduction by low dose Dynasore is mediated through Dynamin 2 inhibition. Thus, we hypothesized that the cardioprotective effect of dynasore is mediated not only by inhibition of Drp1-dependent mitochondrial fission but also the inhibition of Dynamin 2-dependent ROS production. To test this hypothesis, we evaluated ROS production in neonatal cardiomyocytes with Dynamin 2 knockdown by Lv5-shRNA D2 -2. Our results indicate that oxidative stress increases intracellular ROS generation, while Lv5-shRNA D2 -2 treated cardiomyocytes reduces ROS production. Furthermore, with Dynamin 2 knockdown, Dynasore decreases ROS production, with a significant difference between the 10µM Dynasore group and untreated group (P<0.01 Fig. 6 ). However, there was no difference in the increase of levels of ROS production between the mdivi-1 treatment Lv5-shRNA NC and Lv5-shRNA D2 -2 groups (P>0.05, Fig. 6 ). The results suggested that ROS production is dependent on Dynamin 2 activity. 
Discussion
Drp1 inhibition is known to reduce cardiomyocyte death [5] . Combined with earlier studies [9] , our data suggest a critical role of Dynasore in inhibiting Drp1 and mPTP opening in cardiomyocytes subjected to oxidative stress. Furthermore, our study is the first to reveal the role of Dynamin 2 in ROS production independent of the mitochondrial electron transport or xanthine/xanthine oxidase systems [23, 24] , and Dynamin 2 knockdown is anti-apoptosis and pro-survival in neonatal mouse cardiomyocytes.
There are very few published studies on the protective effects of Dynamin 2 inhibition in decreasing mitochondrial fission and apoptotic cell death, and earlier studies have been confined to neurodegenerative or neoplastic diseases and tended to focus on the drug effect on endocytosis [25, 26] . Here we identified that the Dynamin 2 inhibitor Dynasore significantly prevented oxidative stress-induced mitochondrial fission in neonatal mouse cardiomyocytes (Fig. 2) , along with a decrease in cell apoptosis (Fig. 1) . During ischemia, the dynamic balance shifts from fusion to fission, resulting in fragmented and discontinuous mitochondria [5, 27] , as well as mitochondrial outer membrane permeablization, release of apoptotic factors, and activation of apoptosis. Taken together, our results indicated that Dynasore protects cultured primary mouse neonatal cardiomyocytes from oxidative stressinduced cell apoptosis. The underlying mechanism may be maintaining mitochondrial mPTP [28] . Interestingly, 10µM Dynasore and 50µM mdivi-1 both reduced neonatal cardiomyocyte apoptosis (Fig. 1) . While the beneficial effects of Dynasore on survival were dose-dependent, there was a greater reduction of cell apoptosis with 10µM Dynasore pretreatment than 50µM mdivi-1 group (Fig. 1) .
Our study reveals that the protein levels of Dynamin 2 and Drp1 increase significantly when cardiomyocytes were exposed to 30µM H 2 O 2 , which can be significantly reduced by either 10μM Dynasore and 50μM mdivi-1 [5] (Fig. 3) , indicating a role of Dynamin 2 in oxidative stress. Meanwhile, Dynasore produces a lower rate of apoptosis, indicating that Dynamin 2 is involved in cardiomyocyte apoptosis.
Although there is increasing evidence that Drp-1-involved mitochondrial fission is extensive in cardiomyocytes, our present study, to our knowledge, is the first to suggest that Dynamin 2 increases ROS production. The subsequent activation of fission proteinsand GTPase Drp1 enzymatic activity will ultimately affect the structural integrity of mitochondria, creating an imbalance in mitochondrial dynamics, and causing excessive mitochondrial fission, with vicious cycle of apoptosis and necrosis to follow. Our results also support previous observed alterations in Dynamin 2 following hypoxia and ischemia/reperfusion. For example, Singleton found hyperoxia treatment of human pulmonary artery endothelial cells induced recruitment of the vesicular regulator, Dynamin 2, the non-receptor tyrosine kinase, c-Abl, and the NADPH oxidase subunit, p47phox, to caveolin-enriched microdomains [29] . Zamora study suggested Nox as a major source of ROS production during ischemia/ reperfusion [30] . However, whether the Nox family is involved in ROS production outside of the mitochondria is yet to be defined. Dynamin 2, in addition to its classical role leading to the scission of endocyte vesicles at the plasma membrane [31] , has also been implicated in other cellular processes such as: regulation of actin assembly and reorganization through interacting with actin-binding proteins [32, 33] ; disruption of the Dynamin 2-dependent retrograde trafficking of Na+/H+ exchanger-1 contributes to cardiomyocyte apoptosis [34] , and Dynamin 2 is a new connexin partner through an innovating mechanistic model by which Dynamin 2 may control connexin 43 gap junction plaque invagination, endocytosis, recycling and degradation [35] . In the present study, we demonstrated for the first time that Dynamin 2 was a new partner with oxidative stress protein, which may play a fundamental role during the process of oxidative injury. Fish et al reported that the p53 pathway might be mainly responsible for the apoptosis promoted by over expressed Dynamin 2, indicating Dynamin 2 as part of a signaling pathway that can activate the transcription factor p53 and potentially trigger apoptosis [36, 37] . A recent study reported endocytosis has been implicated in the regulation of several signaling
